Alnylam files patent infringement lawsuits against Pfizer and Moderna over mRNA COVID-19 vaccine lipids

ALNYLAM PHARMACEUTICALS, INC.

Filed lawsuits in U.S. District Court for Delaware against Pfizer and Moderna.
Patent No. 11,246,933 covers biodegradable cationic lipids used in mRNA COVID-19 vaccines.
Seeking damages for infringement including a reasonable royalty; no injunction sought.
Alnylam asserts its patented lipids are foundational to the vaccines and used without license.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.